EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Compliance to Competitive Advantage in Pharma Supply
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
KNOWLEDGE BANK
-
Articles
The Impact of Inflation and New Policies on Drug Pricing
Drug pricing has long been a contentious issue balancing the cost of innovation and the need for accessible healthcare In recent years the landscape has grown more complex due to rising inflation
Accelerated Approval Pathways: Speed Without the Stumbles
When a therapy for a devastating disease sits finished in a laboratory while patients wait the arithmetic of a traditional approval timeline becomes unbearable Europes accelerated approval pathways were built precisely for this moment to compress the distance between a promising molecule and a prescription pad
The Impact of Digital Health Technologies on Patient Outcomes
It is also noteworthy that the structure of the healthcare system has shifted rather dynamically in the past few years primarily because of the integration of digital health solutions Such developments
Sustainability in Pharma Manufacturing: A Focus on Green Practices
The pharmaceutical industry is pivotal to global healthcare but its manufacturing processes typically carry a significant environmental burden In recent years there has been an increasing recognition of the importance of sustainability in pharmaceutical manufacturing
The Rise of Personalized Medicine in Europe: Opportunities and Challenges for Pharma Companies
In Europe there is a growing momentum around personalized medicine an inventive method that customizes medical treatments based on individual characteristics As progress in genomics and molecular diagnostics advances
Advanced 3D Cell Models: Moving from Promise to Practice in Drug Discovery
Over the past decade organoids spheroids and other advanced D cell models have transformed how researchers approach disease modelling and drug development Their ability to better reflect human biology than traditional D cultures has generated significant enthusiasm across pharmaceutical research yet widespread adoption remains a work in progress
-
Techno Trends
USF Researchers Identify New P. vivax Vaccine Target
Researchers at USF Health have identified a previously unknown vulnerability in Plasmodium vivax a major malaria parasite found across parts of Asia and Central and South America
-
Projects
Evonik Launches US$94 Million (EUR 80 million) Biotechnology Expansion in Slovakia
Evonik has commenced construction of a new biotechnology expansion at its Fermas facility in Slovensk upa Slovakia The development is part of an approximately US million investment EUR million
-
Research Insights
One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases
Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
Accelerated Approval Pathways: Speed Without the Stumbles
Lakshmi
Europe's expedited routes — conditional marketing authorisation, approval under exceptional circumstances, and the PRIME scheme — let promising therapies reach patients years early by...
-
2
The Impact of Digital Health Technologies on Patient Outcomes
Kate Williamson
Telemedicine and telecare, m-health, wearable devices, electronic health records, and big data analytics are the digital health technologies that are becoming the agents of change in the health care s...
-
3
Sustainability in Pharma Manufacturing: A Focus on Green Practices
Kate Williamson
This article explores the growing emphasis on sustainability in pharmaceutical manufacturing, addressing environmental challenges such as high energy consumption, waste generation, and water usage. It...
-
4
The Rise of Personalized Medicine in Europe: Opportunities and Challenges for Pharma Companies
Kate Williamson
This article explores the burgeoning landscape of personalized medicine in Europe, presenting pharmaceutical companies with opportunities like targeted therapies and market expansion. It delves into s...
-
5
Advanced 3D Cell Models: Moving from Promise to Practice in Drug Discovery
Nicola Bevan
Advanced 3D cell models have been hailed as the future of drug discovery for more than a decade, yet their routine use in pharmaceutical research remains surprisingly limited. As organoids, spheroids...
press releases Read more...
Walden Biosciences to Present Phase 1+ and Phase 2 Data for WAL0921 at American Society of Nephrology Kidney Week
Walden Biosciences Inc Walden or the Company a private clinicalstage biotechnology company dedicated to developing diseasemodifying medicines to treat rare chronic kidney diseases
Century Therapeutics' CNTY-813 Demonstrates Continued Advancement Toward the Clinic Via Nonclinical Data Presented at EASD 2026
Century Therapeutics Inc Century NASDAQ IPSC a biotechnology company developing induced pluripotent stem cell iPSCderived cell therapies for type diabetes TD and other autoimmune
Thewaico Emerges from Stealth with Bioreactor Platform Built to Address Biomanufacturing's Massive Scale-Up Problem
Thewaico a bioprocess innovation company today emerged from stealth with an integrated bioreactor and bioprocess control platform developed to address one of biomanufacturings most persistent and costly failures
Seasoned Biotech Finance Executive Florian Schmid Appointed CFO of T-CURX to Support Next Phase of Growth
TCURX GmbH TCURX a biotechnology company developing nonviral CART therapies today announced the appointment of Florian Schmid as Chief Financial Officer Florian will lead the company
Events Read more...
05 - 06
Oct 2026ISPSAI France 2026
Paris, France
05 - 08
Oct 202616th World CB & CDx Summit 2026
Boston, MA, USA
12 - 13
Oct 2026Pharmaceutics 2026
Village Hotel Changi, Singapor...
12 - 13
Oct 20262nd International Conference on Drug Discovery
Village Hotel Changi, Singapor...
21 - 23
Oct 2026Drug Formulation & Drug Delivery 2026
Paris, France
21 - 22
Oct 2026Advance Clinical Trials and Research 2026
Paris, France
22 - 23
Oct 2026PDA Aseptic Symposium 2026
Congress Square Nakanoshima, O...
26 - 28
Oct 2026ACHEMA Middle East 2026
RICEC, Riyadh, KSA, Saudi Arab...
LATEST NEWS Read more...
Quotient Sciences and Acesion Pharma collaborate on AI-enhanced formulation development
Quotient Sciences and Acesion Pharma have announced a collaboration to use AIenhanced formulation development to support Acesions earlystage pipeline of smallmolecule treatments for atrial fibrillation
Fresenius completes acquisition of mAbxience
Fresenius SE Co KGaA has completed the acquisition of the remaining stake in mAbxience from Insud Pharma giving Fresenius full ownership of the biopharmaceutical company
R1 Therapeutics expands Series A financing to $80.5 million
R Therapeutics has expanded its Series A financing to million with new investment from Samsara BioCapital The clinicalstage biopharmaceutical company will use the funding to advance AP
Immunome receives FDA clearance for IM-1340 clinical trial
Immunome has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application for IM an investigational antibodydrug conjugate ADC being developed for advanced solid tumours
Novonesis Expands West Allis Facility to Strengthen North American Dairy Production
Novonesis has completed a major expansion of its production facility in West Allis Wisconsin increasing its North American capacity for dairy cultures The investment has raised fermentation capacity
4basebio and TriLink BioTechnologies Partner to Support Phase I Cell Therapy Programme
basebio has announced a partnership with TriLink BioTechnologies to support a Phase I cell therapy programme being developed by a multinational pharmaceutical company




